After temporary reprieve, Advanz Pharma’s liver med Ocaliva loses marketing nod in Europe
December 2, 2024Agenus to offer CDMO services as part of its latest reorganization
December 3, 2024RFK Jr. could ‘cost lives in this country’ if he pursues changes to US vaccine policy, Gottlieb says
zbecker
Mon, 12/02/2024 – 16:39
